The Effect of Exercise on Obesity, Body Fat Distribution and Risk for Type 2 Diabetes

Diabetes and Physical Activity

Volumn 60, Issue , 2014, Pages 82-93

  Goedecke, Julia H ^a,c   Micklesfield, Lisa K ^b,c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; FATTY ACID;

ADIPOSE TISSUE; BLOOD; BODY FAT DISTRIBUTION; DIABETES MELLITUS, TYPE 2; EXERCISE; FITNESS; HUMAN; INSULIN RESISTANCE; METABOLISM; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADIPOKINES; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; CYTOKINES; DIABETES MELLITUS, TYPE 2; EXERCISE; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; OBESITY, ABDOMINAL; PHYSICAL FITNESS; RISK FACTORS;

EID: 84929581285     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000357338     Document Type: Chapter

References (102)

1. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
2. Malik VS, Willett WC, Hu FB: Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2012; 9:13-27.
3. Venables MC, Jeukendrup AE: Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev 2009;25:S18-S23.
4. Vague J: The degree of masculine differ- entiation of obesities a factor determin- ing predisposition to diabetes, athero- sclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
5. Group DPPR: 10-year follow-up of dia- betes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-1686.
6. Carey VJ, Walters EE, Colditz GA, et al: Body fat distribution and risk of non- insulin-dependent diabetes mellitus in women. The Nurses' Health Study. A J Epidemiol 1997;145:614-619.
7. Ohlson LO, Larsson B, Svardsudd K, et al: The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the partici- pants in the study of men born in 1913. Diabetes 1985;34:1055-1058.
8. Wang Y, Rimm EB, Stampfer MJ, Wil- lett WC, Hu FB: Comparison of abdomi- nal adiposity and overall obesity in pre- dicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-563.
9. Preis SR, Massaro JM, Robins SJ, et al: Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity 2009;18:2191-2198.
10. Gallagher D, Kelley DE, Yim J-E, et al: Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89:807-814.
11. McLaughlin T, Lamendola C, Liu A, Ab- basi F: Preferential fat deposition in sub- cutaneous versus visceral depots is asso- ciated with insulin sensitivity. J Clin Endocrinol Metab 2011;96:E1756-E1760.
12. Neeland IJ, Turer AT, Ayers CR, et al: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.
13. Richelsen B, Pedersen SB, Moller-Peder- sen T, Bak JF: Regional differences in triglyceride breakdown in human adi- pose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metab Clin Exp 1991;40:990-996.
14. Goedecke JH, Wake DJ, Levitt NS, et al: Glucocorticoid metabolism within su- perficial subcutaneous rather than vis- ceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 2006;65:81-87.
15. Gauthier M-S, O'Brien EL, Bigornia S, et al: Decreased AMP-activated protein kinase activity is associated with in- creased inflammation in visceral adi- pose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 2011; 404:382-387.
16. Alvehus M, Burén J, Sjöström M, Goede- cke J, Olsson T: The human visceral fat depot has a unique inflammatory pro- file. Obesity 2009;18:879-883.
17. Lee M-J, Wu Y, Fried SK: Adipose tissue heterogeneity: implication of depot dif- ferences in adipose tissue for obesity complications. Mol Aspects Med 2013; 34:1-11.
18. Wilding JPH: The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 2007;24:934-945.
19. Foster MT, Pagliassotti MJ: Metabolic alterations following visceral fat removal and expansion: beyond anatomic loca- tion. Adipocyte 2012;1:192-199.
20. Shay CM, Carnethon MR, Church TR, et al: Lower extremity fat mass is associ- ated with insulin resistance in over- weight and obese individuals: The CARDIA Study. Obesity 2011;19:2248-2253.
21. Snijder M, Dekker J, Visser M, et al: As- sociations of hip and thigh circumfer- ences independent of waist circumfer- ence with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003;77:1192-1197.
22. Snijder MB, Dekker JM, Visser M, et al: Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 2004;27:372-377.
23. Manolopoulos KN, Karpe F, Frayn KN: Gluteofemoral body fat as a determinant of metabolic health. Int J Obes Relat Metab Disord 2010;34:949-959.
24. Snijder MB, Visser M, Dekker JM, et al: Low subcutaneous thigh fat is a risk fac- tor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-308.
25. Votruba SB, Jensen MD: Sex differences in abdominal, gluteal, and thigh LPL activity. Am J Physiol Endocrinol Metab 2007;292:E1823-E1828.
26. Manolopoulos KN, Karpe F, Frayn KN: Marked resistance of femoral adipose tissue blood flow and lipolysis to adren- aline in vivo. Diabetologia 2012;55: 3029-3037.
27. Tittelbach TJ, Berman DM, Nicklas BJ, Ryan AS, Goldberg AP: Racial differenc- es in adipocyte size and relationship to the metabolic syndrome in obese wom- en. Obes Res 2004;12:990-998.
28. Hwang JH, Stein DT, Barzilai N, et al: Increased intrahepatic triglyceride is associated with peripheral insulin resis- tance: in vivo MR imaging and spectros- copy studies. Am J Physiol Endocrinol Metab 2007;293:E1663-E1669.
29. Karelis AD: Metabolic and body compo- sition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
30. Conus F, Rabasa-Lhoret R, Péronnet F: Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
31. Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR: Insulin- sensitive obesity in humans - a 'favor- able fat' phenotype? Trends Endocrinol Metab 2012;23:116-124.
32. Storlien L, Oakes ND, Kelley DE: Meta- bolic flexibility. Proc Nutr Soc 2007;63: 363-368.
33. BlÜher M: Are there still healthy obese patients? Curr Opin Endocrinol Diabe- tes Obes 2012;19:341-346.
34. Kruger H, Venter C, Vorster H, Margetts B: Physical inactivity is the major deter- minant of obesity in black women in the North West Province, South Africa: The THUSA study. Nutrition 2002;18:422-427.
35. Cook I, Alberts M, Lambert EV: Rela- tionship between adiposity and pedom- eter-assessed ambulatory activity in adult, rural African women. Int J Obes 2008;32:1327-1330.
36. Friedenreich CM, Woolcott CG, McTier- nan A, et al: Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a ran- domized controlled trial. Int J Obes 2010;35:427-435.
37. Slentz CA, Duscha BD, Johnson JL, et al: Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE - a randomized controlled study. Arch Intern Med 2004;164:31-39.
38. Giannopoulou I: Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin En- docrinol Metab 2004;90:1511-1518.
39. Janssen I, Fortier A, Hudson R, Ross R: Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002;25:431-438.
40. Borel A-L, Nazare J-A, Smith J, et al: Visceral and not subcutaneous abdom- inal adiposity reduction drives the benefits of a 1-year lifestyle modifica- tion program. Obesity 2012;20:1223-1233.
41. Ross R, Janssen I, Dawson J, et al: Exer- cise-induced reduction in obesity and insulin resistance in women: a random- ized controlled trial. Obes Res 2004;12: 789-798.
42. Thompson D, Karpe F, Lafontan M, Frayn K: Physical activity and exercise in the regulation of human adipose tis- sue physiology. Physiol Rev 2012;92: 157-191.
43. Vissers D, Hens W, Taeymans J, Baey- ens J-P, Poortmans J, Van Gaal L: The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One 2013;8:e56415.
44. Hunter GR, Chandler-Laney PC, Brock DW, Lara-Castro C, Fernández JR, Gower BA: Fat distribution, aerobic fitness, blood lipids, and insulin sensitivity in African-American and European-American women. Obesity 2009;18:274-281.
45. Hawley JA: Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004;20:383-393.
46. Yoshioka M, Doucet E, St-Pierre S, et al: Impact of high-intensity exercise on energy expenditure, lipid oxidation and body fatness. Int J Obes Relat Metab Disord 2001;25:332-339.
47. Bajpeyi S, Tanner CJ, Slentz CA, et al: Effect of exercise intensity and volume on persistence of insulin sensitivity dur- ing training cessation. J Appl Physiol 2009;106:1079-1085.
48. Horowitz JF: Fatty acid mobilization from adipose tissue during exercise. Trends Endocrinol Metab 2003;14:386-392.
49. Irving BA, Davis CK, Brock DW, et al: Effect of exercise training intensity on abdominal visceral fat and body compo- sition. Med Sci Sports Exerc 2008;40: 1863-1872.
50. Irwin ML, Yasui Y, Ulrich CM, et al: Effect of exercise on total and intra-ab- dominal body fat in postmenopausal women: a randomized controlled trial. JAMA 2003;289:323-330.
51. McTiernan A, Sorensen B, Irwin ML, et al: Exercise effect on weight and body fat in men and women. Obesity (Silver Spring) 2007;15:1496-1512.
52. Slentz CA: Inactivity, exercise, and vis- ceral fat. STRRIDE: a randomized, con- trolled study of exercise intensity and amount. J Appl Physiol 2005;99:1613-1618.
53. Ohkawara K, Tanaka S, Miyachi M, Ishikawa-Takata K, Tabata I: A dose- response relation between aerobic exer- cise and visceral fat reduction: system- atic review of clinical trials. Int J Obes 2007;31:1786-1797.
54. Larson-Meyer DE, Redman L, Heil- bronn LK, Martin CK, Ravussin E: Ca- loric restriction with or without exer- cise. Med Sci Sports Exerc 2010;42: 152-159.
55. Ross R, Bradshaw AJ: The future of obesity reduction: beyond weight loss. Nature Rev Endocrinol 2009;5:319-325.
56. Ainsworth BE, Haskell WL, Whitt MC, et al: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:S498-S504.
57. Slentz CA, Bateman LA, Willis LH, et al: Effects of aerobic vs. resistance training on visceral and liver fat stores, liver en- zymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/ RT. Am J Physiol Endocrinol Metab 2011;301:E1033-E1039.
58. Willis LH, Slentz CA, Bateman LA, et al: Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol 2012;113:1831-1837.
59. Lynch NA, Nicklas BJ, Berman DM, Dennis KE, Goldberg AP: Reductions in visceral fat during weight loss and walk- ing are associated with improvements in VO(2 max). J Appl Physiol 2001;90:99-104.
60. Wong SL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R: Car- diorespiratory fitness is associated with lower abdominal fat independent of body mass index. Med Sci Sports Exerc 2004;36:286-291.
61. Janssen I, Katzmarzyk P, Ross R, et al: Fitness alters the associations of BMI and waist circumference with total and abdominal fat. Obes Res 2004;12:525-537.
62. Arsenault BJ, Lachance D, Lemieux I, et al: Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 2007;167:1518-1525.
63. De Cocker KA, van Uffelen JGZ, Brown WJ: Associations between sit- ting time and weight in young adult Australian women. Prev Med 2010;51: 361-367.
64. Blanck HM, McCullough ML, Patel AV, et al: Sedentary behavior, recreational physical activity, and 7-year weight gain among postmenopausal US women. Obesity 2007;15:1578-1588.
65. Thorp AA, Owen N, Neuhaus M, Dun- stan DW: Sedentary behaviors and sub- sequent health outcomes in adults. Am J Prevent Med 2011;41:207-215.
66. Proper KI, Singh AS, van Mechelen W, Chinapaw MJM: Sedentary behaviors and health outcomes among adults. Am J Prevent Med 2011;40:174-182.
67. Pavey TG, Peeters G, Brown WJ: Sitting- time and 9-year all-cause mortality in older women. Br J Sports Med, E-pub ahead of print. Hu FB, Li TY, Colditz GA, Willett WC, Manson JE: Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mel- litus in women. JAMA 2003;289:1785-1791.
68. Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, Pedersen BK: Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA 2008; 299:1261-1263.
69. Okura T, Nakata Y, Lee DJ, Ohkawara K, Tanaka K: Effects of aerobic exercise and obesity phenotype on abdominal fat reduction in response to weight loss. Int J Obes 2005;29:1259-1266.
70. Hamdy O, Porramatikul S, Al-Ozairi E: Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Dia- betes Rev 2006;2:367-373.
71. Goedecke JH, Dave JA, Faulenbach MV, et al: Insulin response in relation to in- sulin sensitivity: an appropriate beta-cell response in black South African women. Diabetes Care 2009;32:860-865.
72. Lovejoy JC, la Bretonne de JA, Klemperer M, Tulley R: Abdominal fat distribution and metabolic risk factors: effects of race. Metab Clin Exp 1996;45:1119-1124.
73. Bajaj M, Banerji MA: Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep 2004;4:213-218.
74. Kantartzis K, Machann J, Schick F, et al: Effects of a lifestyle intervention in met- abolically benign and malign obesity. Diabetologia 2010;54:864-868.
75. Hu G, Lindstrom J, Valle TT, et al: Phys- ical activity, body mass index, and risk of type 2 diabetes in patients with nor- mal or impaired glucose regulation. Arch Intern Med 2004;164:892.
76. Weinstein AR, Sesso HD, Lee IM, et al: Relationship of physical activity vs body mass index with type 2 diabetes in wom- en. JAMA 2004;292:1188-1194.
77. Rana JS, Li TY, Manson JE, Hu FB: Adi- posity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007;30:53-58.
78. Fogelholm M: Physical activity, fitness and fatness: relations to mortality, mor- bidity and disease risk factors. A system- atic review. Obes Rev 2010;11:202-221.
79. LaMonte MJ, Blair SN: Physical activity, cardiorespiratory fitness, and adiposity: contributions to disease risk. Curr Opin Clin Nutr Metab Care 2006;9:540-546.
80. Gill JMR, Malkova D: Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resis- tance and obesity. Clin Sci 2006;110:409.
81. Wei M, Kampert JB, Barlow CE, et al: Relationship between low cardiorespira- tory fitness and mortality in normal- weight, overweight, and obese men. JAMA 1999;282:1547-1553.
82. Lee DC, Sui X, Church TS, Lee IM, Blair SN: Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men. Diabetes Care 2008;32:257-262.
83. Sui X, Hooker SP, Lee IM, et al: A pro- spective study of cardiorespiratory fit- ness and risk of type 2 diabetes in wom- en. Diabetes Care 2007;31:550-555.
84. Capurso C, Capurso A: From excess adi- posity to insulin resistance: the role of free fatty acids. Vasc Pharmacol 2012; 57:91-97.
85. Frayn KN: Fat as a fuel: emerging un- derstanding of the adipose tissue-skele- tal muscle axis. Acta Physiol 2010;199: 509-518.
86. Weyer C, Foley JE, Bogardus C, Tataran- ni PA, Pratley RE: Enlarged subcutane- ous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Dia- betologia 2000;43:1498-1506.
87. Hotamisligil GS: Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000;24(suppl 4):S23-S27.
88. Stefanyk LE, Dyck DJ: The interaction between adipokines, diet and exercise on muscle insulin sensitivity. Curr Opin Clin Nutr Metab Care 2010;13:255-259.
89. Simpson KA, Singh MAF: Effects of ex- ercise on adiponectin: a systematic re- view. Obesity 2008;16:241-256.
90. Kloting N, Fasshauer M, Dietrich A, et al: Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515.
91. You T, Nicklas BJ: Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep 2008;8:7-11.
92. Hopps E, Canino B, Caimi G: Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol 2011;48:183-189.
93. Balducci S, Zanuso S, Nicolucci A, et al: Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is depen- dent on exercise modalities and inde- pendent of weight loss. Nutr Metab Car- diovasc Dis 2010;20:608-617.
94. Stensvold D, Slørdahl SA, Wisløff U: Effect of exercise training on inflam- mation status among people with met- abolic syndrome. Metab Syndr Relat Disord 2012;10:267-272.
95. Febbraio MA, Steensberg A, Starkie RL, McConell GK, Kingwell BA: Skel- etal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 dia- betes at rest and during exercise. Metab Clin Exp 2003;52:939-944.
96. Pedersen BK, Febbraio MA: Muscle as an endocrine organ: focus on muscle- derived interleukin-6. Physiol Rev 2008;88:1379-1406.
97. Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK: Exercise and IL-6 infusion inhibit endotoxin- induced TNF-α production in humans. FASEB J 2003;17:884-886.
98. Pedersen BK: The diseasome of physi- cal inactivity and the role of myokines in muscle-fat cross talk. J Physiol 2009; 587:5559-5568.
99. Hagberg JM, Jenkins NT, Spangen- burg E: Exercise training, genetics and type 2 diabetes-related pheno- types. Acta Physiol 2012;205:456-471.
100. Rosen ED, Spiegelman BM: PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-37734.
101. Deeb SS, Fajas L, Nemoto M, et al: A Pro12Ala substitution in PPARgamma2 associated with de- creased receptor activity, lower body mass index and improved insulin sen- sitivity. Nat Genet 1998;20:284-287.
102. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JPT: The Association between the peroxisome proliferator-activated receptor-2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE re- view and meta-analysis. Am J Epide- miol 2010;171:645-655.